Skip to main content
. 2020 Feb 28;2020:2807120. doi: 10.1155/2020/2807120

Table 1.

Patient and disease characteristics of the current study.

Parameter Frequency Number of evaluated patients Percent
Demographic data
Age (years)
 <18 90 159 56.6
 18-35 55 159 34.6
 >35 14 159 8.8
Gender
 Male 90 159 56.6
 Female 69 159 43.4
Splenectomized 52 159 32.7
Serum ferritin (μg/L)
 <1000 122 159 76.7
 >1000 37 159 23.3
Treatment
 None transfused 33 159 20.7
 Occasional transfusion 75 159 47.2
 Regular transfusion 51 159 32.1
 Iron chelation 63 159 39.6
 Hydroxyurea 75 159 47.2
Complications
 Facial deformity 99 159 62.3
Osteoporosis 17 60 28.3
∗∗Growth retardation 17 90 18.9
∗∗∗Subclinical hypothyroidism 22 131 16.8
∗∗∗∗Cholelithiasis 19 137 13.8
 Pulmonary hypertension 18 159 11.3
 Abnormal liver function 12 159 7.5
 Thrombosis 2 159 1.3
 EMH 1 159 0.6
 Leg ulcer 1 159 0.6

Osteoporosis and ∗∗∗subclinical hypothyroidism were evaluated in patients ≥ 10 years old and/or symptomatic, ∗∗growth retardation (height > 2SD below 3rd percentile for the mean age and gender) in patients ≤ 18 years, and ∗∗∗∗cholelithiasis estimated in 137 patients excluding the 22 patients that underwent cholecystectomy.